1120 related articles for article (PubMed ID: 21925627)
1. The enhancement of bone regeneration by a combination of osteoconductivity and osteostimulation using β-CaSiO3/β-Ca3(PO4)2 composite bioceramics.
Wang C; Xue Y; Lin K; Lu J; Chang J; Sun J
Acta Biomater; 2012 Jan; 8(1):350-60. PubMed ID: 21925627
[TBL] [Abstract][Full Text] [Related]
2. Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics.
Xu S; Lin K; Wang Z; Chang J; Wang L; Lu J; Ning C
Biomaterials; 2008 Jun; 29(17):2588-96. PubMed ID: 18378303
[TBL] [Abstract][Full Text] [Related]
3. Osteogenesis and angiogenesis induced by porous β-CaSiO(3)/PDLGA composite scaffold via activation of AMPK/ERK1/2 and PI3K/Akt pathways.
Wang C; Lin K; Chang J; Sun J
Biomaterials; 2013 Jan; 34(1):64-77. PubMed ID: 23069715
[TBL] [Abstract][Full Text] [Related]
4. Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies.
Ni S; Lin K; Chang J; Chou L
J Biomed Mater Res A; 2008 Apr; 85(1):72-82. PubMed ID: 17688291
[TBL] [Abstract][Full Text] [Related]
5. Degradation and silicon excretion of the calcium silicate bioactive ceramics during bone regeneration using rabbit femur defect model.
Lin K; Liu Y; Huang H; Chen L; Wang Z; Chang J
J Mater Sci Mater Med; 2015 Jun; 26(6):197. PubMed ID: 26099345
[TBL] [Abstract][Full Text] [Related]
6. The effect of calcium silicate on in vitro physiochemical properties and in vivo osteogenesis, degradability and bioactivity of porous β-tricalcium phosphate bioceramics.
Liu S; Jin F; Lin K; Lu J; Sun J; Chang J; Dai K; Fan C
Biomed Mater; 2013 Apr; 8(2):025008. PubMed ID: 23428666
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the osteoconductivity of α-tricalcium phosphate, β-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect.
Rojbani H; Nyan M; Ohya K; Kasugai S
J Biomed Mater Res A; 2011 Sep; 98(4):488-98. PubMed ID: 21681941
[TBL] [Abstract][Full Text] [Related]
8. A biodegradable porous composite scaffold of PGA/beta-TCP for bone tissue engineering.
Cao H; Kuboyama N
Bone; 2010 Feb; 46(2):386-95. PubMed ID: 19800045
[TBL] [Abstract][Full Text] [Related]
9. The stimulation of osteogenic differentiation of mesenchymal stem cells and vascular endothelial growth factor secretion of endothelial cells by β-CaSiO3/β-Ca3(PO4)2 scaffolds.
Wang C; Lin K; Chang J; Sun J
J Biomed Mater Res A; 2014 Jul; 102(7):2096-104. PubMed ID: 23894078
[TBL] [Abstract][Full Text] [Related]
10. In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics.
Ni S; Chang J
J Biomater Appl; 2009 Aug; 24(2):139-58. PubMed ID: 18801892
[TBL] [Abstract][Full Text] [Related]
11. Advanced bioceramic composite for bone tissue engineering: design principles and structure-bioactivity relationship.
El-Ghannam AR
J Biomed Mater Res A; 2004 Jun; 69(3):490-501. PubMed ID: 15127396
[TBL] [Abstract][Full Text] [Related]
12. Novel Extrusion-Microdrilling Approach to Fabricate Calcium Phosphate-Based Bioceramic Scaffolds Enabling Fast Bone Regeneration.
He F; Lu T; Fang X; Feng S; Feng S; Tian Y; Li Y; Zuo F; Deng X; Ye J
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32340-32351. PubMed ID: 32597161
[TBL] [Abstract][Full Text] [Related]
13. Regulation of physicochemical properties, osteogenesis activity, and fibroblast growth factor-2 release ability of β-tricalcium phosphate for bone cement by calcium silicate.
Su CC; Kao CT; Hung CJ; Chen YJ; Huang TH; Shie MY
Mater Sci Eng C Mater Biol Appl; 2014 Apr; 37():156-63. PubMed ID: 24582235
[TBL] [Abstract][Full Text] [Related]
14. Development of calcium silicate/calcium phosphate cement for bone regeneration.
Guo H; Wei J; Yuan Y; Liu C
Biomed Mater; 2007 Sep; 2(3):S153-9. PubMed ID: 18458461
[TBL] [Abstract][Full Text] [Related]
15. High biocompatibility and improved osteogenic potential of novel Ca-P/titania composite scaffolds designed for regeneration of load-bearing segmental bone defects.
Cunha C; Sprio S; Panseri S; Dapporto M; Marcacci M; Tampieri A
J Biomed Mater Res A; 2013 Jun; 101(6):1612-9. PubMed ID: 23172612
[TBL] [Abstract][Full Text] [Related]
16. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application.
Abarrategi A; Moreno-Vicente C; Ramos V; Aranaz I; Sanz Casado JV; López-Lacomba JL
Tissue Eng Part A; 2008 Aug; 14(8):1305-19. PubMed ID: 18491953
[TBL] [Abstract][Full Text] [Related]
17. The primacy of octacalcium phosphate collagen composites in bone regeneration.
Kamakura S; Sasaki K; Homma T; Honda Y; Anada T; Echigo S; Suzuki O
J Biomed Mater Res A; 2007 Dec; 83(3):725-33. PubMed ID: 17559110
[TBL] [Abstract][Full Text] [Related]
18. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin.
Xie XH; Wang XL; Zhang G; He YX; Wang XH; Liu Z; He K; Peng J; Leng Y; Qin L
Biomed Mater; 2010 Oct; 5(5):054109. PubMed ID: 20876954
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluations of 3D porous TCP-coated and non-coated alumina scaffolds.
Kim YH; Anirban JM; Song HY; Seo HS; Lee BT
J Biomater Appl; 2011 Feb; 25(6):539-58. PubMed ID: 20207781
[TBL] [Abstract][Full Text] [Related]
20. Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition.
Kamitakahara M; Ohtsuki C; Miyazaki T
J Biomater Appl; 2008 Nov; 23(3):197-212. PubMed ID: 18996965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
